Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative
- PMID: 34421200
- PMCID: PMC8329011
- DOI: 10.2337/cd21-0029
Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative
Abstract
Despite immense strides in therapeutic advances, clinical outcomes continue to be less than ideal for people with type 1 diabetes. This discrepancy has prompted an outpouring of quality improvement (QI) initiatives to address the medical, psychosocial, and health equity challenges that complicate ideal type 1 diabetes care and outcomes. This article reviews a framework for QI in diabetes care that guided the development of the T1D Exchange Quality Improvement Collaborative to improve care delivery and health outcomes in type 1 diabetes. Evaluation of the methodology, outcomes, and knowledge gained from these initiatives will highlight the importance of continued QI initiatives in diabetes care.
© 2021 by the American Diabetes Association.
Conflict of interest statement
O.E. is a compensated Health Equity Advisory Board member for Medtronic Diabetes and serves as the principal investigator for investigator-led projects sponsored by Abbott, Dexcom, Eli Lilly, Insulet, and Medtronic. J.M.L. is on the medical advisory board for GoodRx. D.J.D. is a consultant to Dexcom and Insulet. No other potential conflicts of interest relevant to this article were reported.
Figures
References
-
- American Diabetes Association . Statistics about diabetes. Available from https://www.diabetes.org/resources/statistics/statistics-about-diabetes. Accessed 27 October 2020
-
- DCCT Research Group . Diabetes Control and Complications Trial (DCCT): update. Diabetes Care 1990;13:427–433 - PubMed
-
- Gosmanov AR, Gosmanova EO. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the DCCT/EDIC cohort. Arch Intern Med 2011;171:1596; author reply 1597 - PubMed